vs
Ecovyst Inc.（ECVT）与Sotera Health Co（SHC）财务数据对比。点击上方公司名可切换其他公司
Sotera Health Co的季度营收约是Ecovyst Inc.的1.5倍（$303.4M vs $199.4M），Ecovyst Inc.同比增速更快（34.0% vs 4.6%），Sotera Health Co自由现金流更多（$52.4M vs $22.9M），过去两年Ecovyst Inc.的营收复合增速更高（18.7% vs 10.6%）
Ecovyst Inc.是一家全球可持续特种材料供应商，主营高性能催化剂与功能性添加剂的研发、生产，产品服务覆盖工业制造、消费品、环保等核心领域，助力全球客户提升运营效率、降低碳排放。
Sotera Health Co是全球领先的医疗安全解决方案提供商，面向医疗器械厂商、制药企业、食品及消费品公司提供灭菌服务、实验室分析检测与合规咨询支持，帮助客户满足监管要求，保障上市产品的使用安全。
ECVT vs SHC — 直观对比
营收规模更大
SHC
是对方的1.5倍
$199.4M
营收增速更快
ECVT
高出29.4%
4.6%
自由现金流更多
SHC
多$29.5M
$22.9M
两年增速更快
ECVT
近两年复合增速
10.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.4M | $303.4M |
| 净利润 | — | $34.8M |
| 毛利率 | 23.4% | 54.7% |
| 营业利润率 | 10.9% | 23.2% |
| 净利率 | — | 11.5% |
| 营收同比 | 34.0% | 4.6% |
| 净利润同比 | — | 182.8% |
| 每股收益（稀释后） | $0.06 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ECVTSHC
| Q4 25 | $199.4M | $303.4M | ||
| Q3 25 | $204.9M | $311.3M | ||
| Q2 25 | $176.1M | $294.3M | ||
| Q1 25 | $143.1M | $254.5M | ||
| Q4 24 | $148.9M | $290.2M | ||
| Q3 24 | $153.9M | $285.5M | ||
| Q2 24 | $154.0M | $276.6M | ||
| Q1 24 | $141.6M | $248.2M |
净利润ECVTSHC
| Q4 25 | — | $34.8M | ||
| Q3 25 | $-79.3M | $48.4M | ||
| Q2 25 | $6.0M | $8.0M | ||
| Q1 25 | $-3.6M | $-13.3M | ||
| Q4 24 | — | $12.3M | ||
| Q3 24 | $14.3M | $17.0M | ||
| Q2 24 | $8.3M | $8.8M | ||
| Q1 24 | $1.2M | $6.3M |
毛利率ECVTSHC
| Q4 25 | 23.4% | 54.7% | ||
| Q3 25 | 25.4% | 57.0% | ||
| Q2 25 | 22.8% | 56.6% | ||
| Q1 25 | 13.3% | 53.2% | ||
| Q4 24 | 28.9% | 56.6% | ||
| Q3 24 | 29.3% | 55.4% | ||
| Q2 24 | 27.3% | 55.2% | ||
| Q1 24 | 23.5% | 51.2% |
营业利润率ECVTSHC
| Q4 25 | 10.9% | 23.2% | ||
| Q3 25 | 13.8% | 23.4% | ||
| Q2 25 | 9.0% | 6.4% | ||
| Q1 25 | -0.7% | -5.8% | ||
| Q4 24 | 15.1% | 30.0% | ||
| Q3 24 | 17.9% | 28.2% | ||
| Q2 24 | 14.1% | 27.8% | ||
| Q1 24 | 9.5% | 21.4% |
净利率ECVTSHC
| Q4 25 | — | 11.5% | ||
| Q3 25 | -38.7% | 15.5% | ||
| Q2 25 | 3.4% | 2.7% | ||
| Q1 25 | -2.5% | -5.2% | ||
| Q4 24 | — | 4.2% | ||
| Q3 24 | 9.3% | 6.0% | ||
| Q2 24 | 5.4% | 3.2% | ||
| Q1 24 | 0.9% | 2.5% |
每股收益（稀释后）ECVTSHC
| Q4 25 | $0.06 | $0.12 | ||
| Q3 25 | $-0.69 | $0.17 | ||
| Q2 25 | $0.05 | $0.03 | ||
| Q1 25 | $-0.03 | $-0.05 | ||
| Q4 24 | $-0.26 | $0.05 | ||
| Q3 24 | $0.12 | $0.06 | ||
| Q2 24 | $0.07 | $0.03 | ||
| Q1 24 | $0.01 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $197.2M | $344.6M |
| 总债务越低越好 | $392.6M | $2.1B |
| 股东权益账面价值 | $603.4M | $606.0M |
| 总资产 | $1.3B | $3.3B |
| 负债/权益比越低杠杆越低 | 0.65× | 3.53× |
8季度趋势，按日历期对齐
现金及短期投资ECVTSHC
| Q4 25 | $197.2M | $344.6M | ||
| Q3 25 | $82.0M | $299.2M | ||
| Q2 25 | $69.6M | $332.4M | ||
| Q1 25 | $127.5M | $304.4M | ||
| Q4 24 | $131.4M | $277.2M | ||
| Q3 24 | $123.5M | $306.7M | ||
| Q2 24 | $83.3M | $246.1M | ||
| Q1 24 | $103.1M | $261.1M |
总债务ECVTSHC
| Q4 25 | $392.6M | $2.1B | ||
| Q3 25 | $854.8M | $2.1B | ||
| Q2 25 | $856.6M | $2.2B | ||
| Q1 25 | $859.0M | $2.2B | ||
| Q4 24 | $860.8M | $2.2B | ||
| Q3 24 | $862.7M | $2.2B | ||
| Q2 24 | $862.4M | $2.2B | ||
| Q1 24 | $866.2M | $2.2B |
股东权益ECVTSHC
| Q4 25 | $603.4M | $606.0M | ||
| Q3 25 | $607.9M | $550.5M | ||
| Q2 25 | $692.4M | $511.3M | ||
| Q1 25 | $698.7M | $414.1M | ||
| Q4 24 | $700.5M | $404.9M | ||
| Q3 24 | $729.4M | $470.2M | ||
| Q2 24 | $717.3M | $422.8M | ||
| Q1 24 | $711.4M | $429.4M |
总资产ECVTSHC
| Q4 25 | $1.3B | $3.3B | ||
| Q3 25 | $1.7B | $3.2B | ||
| Q2 25 | $1.8B | $3.2B | ||
| Q1 25 | $1.8B | $3.1B | ||
| Q4 24 | $1.8B | $3.1B | ||
| Q3 24 | $1.8B | $3.1B | ||
| Q2 24 | $1.8B | $3.1B | ||
| Q1 24 | $1.8B | $3.1B |
负债/权益比ECVTSHC
| Q4 25 | 0.65× | 3.53× | ||
| Q3 25 | 1.41× | 3.89× | ||
| Q2 25 | 1.24× | 4.34× | ||
| Q1 25 | 1.23× | 5.36× | ||
| Q4 24 | 1.23× | 5.49× | ||
| Q3 24 | 1.18× | 4.73× | ||
| Q2 24 | 1.20× | 5.26× | ||
| Q1 24 | 1.22× | 5.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $41.8M | $103.1M |
| 自由现金流经营现金流 - 资本支出 | $22.9M | $52.4M |
| 自由现金流率自由现金流/营收 | 11.5% | 17.3% |
| 资本支出强度资本支出/营收 | 9.4% | 16.7% |
| 现金转化率经营现金流/净利润 | — | 2.96× |
| 过去12个月自由现金流最近4个季度 | $69.9M | $149.2M |
8季度趋势，按日历期对齐
经营现金流ECVTSHC
| Q4 25 | $41.8M | $103.1M | ||
| Q3 25 | $55.3M | $71.2M | ||
| Q2 25 | $33.0M | $57.4M | ||
| Q1 25 | $10.3M | $55.5M | ||
| Q4 24 | $43.5M | $55.7M | ||
| Q3 24 | $59.9M | $97.5M | ||
| Q2 24 | $10.0M | $61.3M | ||
| Q1 24 | $36.5M | $9.7M |
自由现金流ECVTSHC
| Q4 25 | $22.9M | $52.4M | ||
| Q3 25 | $53.2M | $35.0M | ||
| Q2 25 | $7.8M | $26.2M | ||
| Q1 25 | $-14.0M | $35.6M | ||
| Q4 24 | $30.9M | $-10.2M | ||
| Q3 24 | $53.6M | $61.1M | ||
| Q2 24 | $-9.3M | $19.4M | ||
| Q1 24 | $19.1M | $-25.2M |
自由现金流率ECVTSHC
| Q4 25 | 11.5% | 17.3% | ||
| Q3 25 | 26.0% | 11.2% | ||
| Q2 25 | 4.4% | 8.9% | ||
| Q1 25 | -9.8% | 14.0% | ||
| Q4 24 | 20.7% | -3.5% | ||
| Q3 24 | 34.9% | 21.4% | ||
| Q2 24 | -6.1% | 7.0% | ||
| Q1 24 | 13.5% | -10.2% |
资本支出强度ECVTSHC
| Q4 25 | 9.4% | 16.7% | ||
| Q3 25 | 1.0% | 11.6% | ||
| Q2 25 | 14.4% | 10.6% | ||
| Q1 25 | 16.9% | 7.8% | ||
| Q4 24 | 8.5% | 22.7% | ||
| Q3 24 | 4.1% | 12.7% | ||
| Q2 24 | 12.5% | 15.2% | ||
| Q1 24 | 12.3% | 14.1% |
现金转化率ECVTSHC
| Q4 25 | — | 2.96× | ||
| Q3 25 | — | 1.47× | ||
| Q2 25 | 5.52× | 7.21× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4.52× | ||
| Q3 24 | 4.21× | 5.73× | ||
| Q2 24 | 1.20× | 7.00× | ||
| Q1 24 | 29.90× | 1.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ECVT
| Industrial Mining Automotive | $101.3M | 51% |
| Regeneration And Treatment Services | $90.0M | 45% |
| Other | $8.1M | 4% |
SHC
| Transferred At Point In Time | $198.4M | 65% |
| Nelson Labs | $55.2M | 18% |
| Nordion | $49.8M | 16% |
